ALSTONIA BIO Trademark

Trademark Overview

On Monday, September 16, 2024, a trademark application was filed for ALSTONIA BIO with the United States Patent and Trademark Office. The USPTO has given the ALSTONIA BIO trademark a serial number of 98752722. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, April 7, 2025. This trademark is owned by ThinkBio.Ai, Inc.. The ALSTONIA BIO trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
alstonia bio

General Information

Serial Number98752722
Word MarkALSTONIA BIO
Filing DateMonday, September 16, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, April 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
NOT AVAILABLE"BIO"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, September 16, 2024
Primary Code035
First Use Anywhere DateThursday, June 29, 2023
First Use In Commerce DateThursday, June 29, 2023

Trademark Owner History

Party NameThinkBio.Ai, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeal Beach, CA 90740-2751

Trademark Events

Event DateEvent Description
Monday, September 16, 2024NEW APPLICATION ENTERED
Friday, January 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 14, 2025ASSIGNED TO EXAMINER
Friday, March 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 21, 2025NON-FINAL ACTION E-MAILED
Friday, March 21, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 7, 2025FINAL REFUSAL WRITTEN
Monday, April 7, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 7, 2025FINAL REFUSAL E-MAILED

Related Keywords

alstonia clinical management trials assist companies biotechnology them research approval biopharmaceutical